|
Product class:
|
Medicinal product with marketing authorization
|
|
Medicinal product class:
|
Veterinary medicine
|
|
Name of medicinal product:
|
Advantage
|
|
Active substances:
|
|
|
ATC code:
|
QP53AX17
|
|
Dosage form:
|
spot-on solution
|
|
Strength:
|
40mg 0.4ml
|
|
Legal status for supply*:
|
Not subject to medicinal prescription
|
|
Summary of product characteristics (SPC):
|
 (last updated 28 January 2022)
|
|
Package information leaflet (PIL):
|
EST (last updated 28 January 2022)
|
|
Labelling:
|
(last updated 28 January 2022)
|
|
Indication:
|
|
|
Safety features:
|
No
|
|
Marketing authorization holder:
|
Bayer Animal Health GmbH
|
|
Marketing authorization number:
|
1456
|
|
Marketing authorization issued on:
|
02 March 2007
|
|
Marketing authorization expires on:
|
Unlimited
|
|
Marketing authorization procedure type:
|
National
|
|
Assessment report:
|
|
|
Package code
|
Name of medicinal product
|
Dosage form
|
Package
|
Legal status
|
Reimbursements
|
Reference price
|
Last imported
|
PƤritolumaa
|
Additional information
|
|
1087455
|
Advantage
|
spot-on solution
|
40mg 0.4ml 0.4ml 4TK
|
OTC
|
|
|
24/11/2023
|
|
kassidele
|
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription